Baroda BNP Paribas ESG Best-in-Class Strategy Fund vs SBI Healthcare Opportunities Fund
Direct Plan, Growth option · Data as on 30-10-2026
Baroda BNP Paribas ESG Best-in-Class Strategy Fund is a Thematic fund and SBI Healthcare Opportunities Fund is a Thematic fund. Baroda BNP Paribas ESG Best-in-Class Strategy Fund charges 1.15% a year and SBI Healthcare Opportunities Fund 1.01% (Direct plans). Their portfolios overlap 5.9%: they hold 3 of the same securities.
Baroda BNP Paribas ESG Best-in-Class Strategy Fund
Thematic
- Expense ratio
- 1.15%
- NAV
- ₹9.97
SBI Healthcare Opportunities Fund
Thematic
- Expense ratio
- 1.01%
- NAV
- ₹588.16
Which is better, Baroda BNP Paribas ESG Best-in-Class Strategy or SBI Healthcare Opportunities? Key differences
It depends on what you want from the fund. These are the differences in numbers, from the data on this page.
- SBI Healthcare Opportunities costs less: 1.01% a year against 1.15% (Direct plans).
- Baroda BNP Paribas ESG Best-in-Class Strategy fell less in its worst fall since 06-03-2026: −10.2% against −10.3%.
- Baroda BNP Paribas ESG Best-in-Class Strategy holds more in large companies: 74.5% of the fund in large caps against 32.3%.
- SBI Healthcare Opportunities is the larger fund: ₹5,870 Cr against ₹564 Cr.
- Their portfolios overlap 5.9%: 3 of the same holdings.
Past returns do not promise future returns. This page is information, not investment advice.
Key facts
From each fund's scheme summary document and AMFI
| Fact | Baroda BNP Paribas ESG Best-in-Class Strategy Fund | SBI Healthcare Opportunities Fund |
|---|---|---|
| Fund house | Baroda BNP Paribas Mutual Fund | SBI Mutual Fund |
| Category | Thematic | Thematic |
| AUM | ₹564 Cr (30-09-2026) | ₹5,870 Cr (30-09-2026) |
| NAV | ₹9.97 (Direct) | ₹588.16 (Direct) |
| Expense ratio (Direct) | 1.15% | 1.01% |
| Expense ratio (Regular) | 2.69% | 1.99% |
| Riskometer | Not available | Not available |
| Benchmark | Not available | Not available |
| Launch date | Not available | Not available |
| Minimum investment | Not available | Not available |
| Lock in | Not available | Not available |
| Fund managers | Not available | Not available |
| Exit load | Not available | Not available |
Baroda BNP Paribas ESG Best-in-Class Strategy vs SBI Healthcare Opportunities: Returns Comparison
Returns as on 30-10-2026. Up to one year they are absolute returns. Longer periods are a rate per year.
| Fund | 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y |
|---|---|---|---|---|---|---|---|
| Baroda BNP Paribas ESG Best-in-Class Strategy Fund (Direct) | +0.72% | −6.11% | −2.75% | -- | -- | -- | -- |
| SBI Healthcare Opportunities Fund (Direct) | +0.31% | −0.59% | +16.00% | +17.12% | +24.60% | +19.22% | +14.72% |
| Thematic average | −2.09% | −4.52% | +0.86% | −1.22% | +13.76% | +11.62% | +13.76% |
Category average: the average of the 235 Thematic funds, same plan type.
Baroda BNP Paribas ESG Best-in-Class Strategy vs SBI Healthcare Opportunities: Year-wise Returns
| Year | Baroda BNP Paribas ESG Best-in-Class StrategyBaroda BNP Paribas ESG Best-in-Class Strategy | SBI Healthcare OpportunitiesSBI Healthcare Opportunities |
|---|---|---|
| 2026to date | -- | +21.31% |
| 2025 | -- | −2.50% |
| 2024 | -- | +43.75% |
| 2023 | -- | +39.72% |
| 2022 | -- | −5.01% |
| 2021 | -- | +21.48% |
Baroda BNP Paribas ESG Best-in-Class Strategy vs SBI Healthcare Opportunities: Rolling Returns
Every holding period of both funds, against NIFTY100 ESG TRI, the benchmark of Baroda BNP Paribas ESG Best-in-Class Strategy Fund
Baroda BNP Paribas ESG Best-in-Class Strategy vs SBI Healthcare Opportunities: Risk and Drawdowns
How much each fund swings, and the worst fall over the same days
Risk and return
| Measure | Baroda BNP Paribas ESG Best-in-Class Strategy Fund (Direct) | SBI Healthcare Opportunities Fund (Direct) |
|---|---|---|
| Return (CAGR) | −0.67% | +17.93% |
| Standard deviation | 10.71% | 15.96% |
| Sharpe ratio | -0.55 | 0.74 |
| Sortino ratio | -0.74 | 1.05 |
| Maximum drawdown | −10.2% (08-10-2026) | −30.5% (23-03-2020) |
| Beta | 0.61 | 0.91 |
| Alpha | −1.36% | +3.97% |
From daily NAVs, 06-03-2026 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
Drawdowns
How far below its previous high each one was on every day: the falls an investor had to sit through. 0% means it was at a new high.
Baroda BNP Paribas ESG Best-in-Class Strategy Fund (Direct)
SBI Healthcare Opportunities Fund (Direct)
NIFTY100 ESG TRI
| Fund | Worst fall | High before it | Bottom | Back at the high | Time to climb back | Below its high today |
|---|---|---|---|---|---|---|
| Baroda BNP Paribas ESG Best-in-Class Strategy Fund (Direct) | −10.2% | 10-08-2026 | 08-10-2026 | Not yet | -- | −7.9% |
| SBI Healthcare Opportunities Fund (Direct) | −10.3% | 21-09-2026 | 23-10-2026 | Not yet | -- | −3.8% |
| NIFTY100 ESG TRI | −11.4% | 03-08-2026 | 08-10-2026 | Not yet | -- | −8.0% |
From daily values since 06-03-2026, the first day every fund has.
Baroda BNP Paribas ESG Best-in-Class Strategy vs SBI Healthcare Opportunities: Portfolio Overlap
From each fund's latest monthly portfolio: Baroda BNP Paribas ESG Best-in-Class Strategy Fund, September 2026; SBI Healthcare Opportunities Fund, September 2026
Holdings in common
- Overlap
- 5.9%
- Held by both
- 3
- Only in Baroda BNP Paribas ESG Best-in-Class Strategy
- 49
- Only in SBI Healthcare Opportunities
- 33
| Security | % of Baroda BNP Paribas ESG Best-in-Class Strategy | % of SBI Healthcare Opportunities |
|---|---|---|
| Torrent Pharmaceuticals Limited | 2.81% | 4.42% |
| Apollo Hospitals Enterprise Limited | 1.59% | 4.45% |
| Divi's Laboratories Limited | 1.51% | 7.91% |
Overlap: for each holding both funds own, the smaller of its two weights, added up. 5.9% means 5.9% of each fund's money sits in positions the other also holds. Matched by ISIN. Cash and hedged positions are left out.
Largest holdings only in Baroda BNP Paribas ESG Best-in-Class Strategy Fund
| Security | % of fund |
|---|---|
| ICICI Bank Limited | 7.02% |
| Bharti Airtel Limited | 6.02% |
| HDFC Bank Limited | 5.42% |
| Infosys Limited | 4.76% |
| Eternal Limited | 4.34% |
Largest holdings only in SBI Healthcare Opportunities Fund
| Security | % of fund |
|---|---|
| Sun Pharmaceutical Industries Ltd. | 11.14% |
| Acutaas Chemicals Ltd. | 5.03% |
| Cipla Ltd. | 4.40% |
| Laurus Labs Ltd. | 4.05% |
| Max Healthcare Institute Ltd. | 3.80% |
Asset and sector split
Share of each fund, from its latest monthly portfolio
Asset allocation
| Asset | Baroda BNP Paribas ESG Best-in-Class Strategy | SBI Healthcare Opportunities |
|---|---|---|
| Equity | 96.3% | 95.5% |
| Debt | 1.7% | 0.1% |
| Cash and others | 2.0% | 4.4% |
Market cap of stocks
| Market cap | Baroda BNP Paribas ESG Best-in-Class Strategy | SBI Healthcare Opportunities |
|---|---|---|
| Large Cap | 74.5% | 32.3% |
| Mid Cap | 12.6% | 25.7% |
| Small Cap | 9.1% | 35.4% |
| Not on AMFI's list | 0.0% | 2.2% |
Share of the whole fund. Groups follow AMFI's latest list: Large Cap is the 100 largest companies, Mid Cap the next 150, Small Cap the rest.
Largest sectors
| Sector | Baroda BNP Paribas ESG Best-in-Class Strategy | SBI Healthcare Opportunities |
|---|---|---|
| Pharmaceuticals & Biotechnology | 4.3% | 63.1% |
| Healthcare Services | 1.6% | 25.6% |
| Banks | 19.1% | 0.0% |
| IT - Software | 10.9% | 0.0% |
| Automobiles | 9.4% | 0.0% |
| Telecom - Services | 6.0% | 0.0% |
| Retailing | 5.7% | 0.0% |
| Power | 5.5% | 0.0% |
| Chemicals & Petrochemicals | 3.6% | 5.0% |
| Healthcare Equipment & Supplies | 0.0% | 1.8% |
The six largest sectors of each fund's stocks, % of the fund.
Baroda BNP Paribas ESG Best-in-Class Strategy vs SBI Healthcare Opportunities: Expense Ratio
What each plan charges a year, from AMFI's expense ratio file
| Charge | Baroda BNP Paribas ESG Best-in-Class Strategy Fund | SBI Healthcare Opportunities Fund |
|---|---|---|
| Total expense ratio (Direct) | 1.15% | 1.01% |
| Base expense ratio (Direct) | 0.75% | 0.74% |
| Total expense ratio (Regular) | 2.69% | 1.99% |
| Base expense ratio (Regular) | 2.06% | 1.58% |
The expense ratio comes out of the fund's assets every day, so every return on this page is already after it. Base expense ratio: the fund house's own fee. The total adds brokerage, transaction costs, and levies with GST.
More comparisons
Each fund against the others of its category
Compare Baroda BNP Paribas ESG Best-in-Class Strategy with
- Baroda BNP Paribas ESG Best-in-Class Strategy vs Nippon India Taiwan Equity
- Baroda BNP Paribas ESG Best-in-Class Strategy vs HDFC Defence
- Baroda BNP Paribas ESG Best-in-Class Strategy vs HDFC Pharma and Healthcare
- Baroda BNP Paribas ESG Best-in-Class Strategy vs Aditya Birla Sun Life International Equity
Baroda BNP Paribas ESG Best-in-Class Strategy Fund vs SBI Healthcare Opportunities Fund: Frequently Asked Questions
What is the difference between Baroda BNP Paribas ESG Best-in-Class Strategy Fund and SBI Healthcare Opportunities Fund?
Baroda BNP Paribas ESG Best-in-Class Strategy Fund is a Thematic fund, SBI Healthcare Opportunities Fund is a Thematic fund, run by Baroda BNP Paribas Mutual Fund and SBI Mutual Fund. Their portfolios overlap 5.9%. Baroda BNP Paribas ESG Best-in-Class Strategy Fund charges 1.15% a year and SBI Healthcare Opportunities Fund 1.01%.
Which has the lower expense ratio, Baroda BNP Paribas ESG Best-in-Class Strategy Fund or SBI Healthcare Opportunities Fund?
SBI Healthcare Opportunities Fund charges less: 1.01% a year against 1.15%. These are the Direct plans' total expense ratios reported to AMFI.
How much do Baroda BNP Paribas ESG Best-in-Class Strategy Fund and SBI Healthcare Opportunities Fund overlap?
5.9%. They hold 3 of the same securities, the largest shared ones being TORNTPHARM, APOLLOHOSP, DIVISLAB. From each fund's latest monthly portfolio.
Can I invest in both Baroda BNP Paribas ESG Best-in-Class Strategy Fund and SBI Healthcare Opportunities Fund?
Yes. 5.9% of each fund's money sits in the same holdings, so the two hold mostly different investments.
Sources: NAV and expense ratio from AMFI. Holdings from each fund house's monthly portfolio statement. Fund facts from each scheme summary document.
This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.